Home›Companies›Biotech & Pharma›BioSolution Designs

BioSolution Designs, Inc.

Develops and licenses biotechnology tools for companies developing therapies.

Updated Nov 11, 2026·Latest SEC filing Mar 12, 2026·Suggest an edit

About BioSolution Designs

BioSolution Designs is a private company based in Frederick, Maryland, incorporated in 2022 in Delaware. It has reported $705,000 raised in one offering on Form D since March 2026. Its chief executive is Thomas Reed.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 9, 2026Mar 12, 2026$705,000of $1.5M target9$78,333EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BioSolution Designs's Form D filed Mar 12, 2026.

TR
Thomas Reed
Founder & CEO, director
JM
John Maslowski
Board of Directors
DS
Daniel Shelly
Board of Directors

Sources

  1. SECBioSolution Designs, Inc. filing history